Hit-to-Lead Optimization of Energy-Coupling Factor (ECF) Transporter Inhibitors as Novel Antibiotic

Le résumé fourni par la source

High Resolution Image Download MS PowerPoint Slide Multiparameter optimization of a previously identified class of inhibitors of the energy-coupling factor (ECF) transporters enabled the confirmation of in vivo efficacy. ECFs are a class of transmembrane proteins that play a vital role in the active translocation of essential nutrients across cell membranes and are therefore important in the fight against antimicrobial resistance. Aiming to improve the drug-like properties of our inhibitory class, we performed a focused structure–activity relationship study around the Eastern part of our starting molecule 3 by exploiting click chemistry. Our multiparameter optimization resulted in compounds with enhanced metabolic stability and solubility, potent activity against both a panel of Gram-positive bacteria, and against the ECF transporters. We further demonstrate rapid bacterial killing using Enterococcus faecium as a model organism and confirmed in vivo efficacy of the best compounds in Galleria mellonella larvae and Danio rerio (zebrafish) infection models, highlighting the therapeutic potential of our approach.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.